Oryzon Genomics Eulerpool Ziņas

Oryzon Genomics Eulerpool News

Oryzon Genomics Akciju Ziņas

Oryzon Genomics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Oryzon Genomics ziņas mēs apkopojam šeit.

• 31. jūlijs ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8. jūlijs ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28. jūnijs ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26. jūnijs ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14. jūnijs ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3. jūnijs ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30. maijs ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29. maijs ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
• 9. maijs ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in May
• 6. maijs ·

  Yahoo
  ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024